{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:24:07Z","timestamp":1789392247843,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejphar.2023.176083","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:05:31Z","timestamp":1695762331000},"page":"176083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs\/NF\u03baB\/NOX1 signaling"],"prefix":"10.1016","volume":"959","author":[{"given":"Afnan","family":"Harb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1773","authenticated-orcid":false,"given":"Mahmoud H.","family":"Elbatreek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elshahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1830-7150","authenticated-orcid":false,"given":"Nadia","family":"El-Akabawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen MIM.","family":"Elkomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176083_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-3-319-60324-7_19","article-title":"Advanced glycation end products (AGEs) in diabetic complications","author":"Bhat","year":"2017","journal-title":"Mech. Vasc. Defects Diabetes Mellitus"},{"key":"10.1016\/j.ejphar.2023.176083_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176083_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118990","article-title":"Behavioral characterization of mouse models of neuroferritinopathy","volume":"10","author":"Capoccia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176083_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/antiox9020142","article-title":"Redox signaling and advanced glycation endproducts (AGEs) in diet-related diseases","volume":"9","author":"Cepas","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2023.176083_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6823058","article-title":"AGE\/RAGE-Induced EMP release via the NOX-derived ROS pathway","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2023.176083_bib6","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1038\/sj.ki.5002387","article-title":"Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes","volume":"Supplement","author":"Coughlan","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2023.176083_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/en.2006-1300","article-title":"Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?","volume":"148","author":"Coughlan","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2023.176083_bib8","first-page":"88","article-title":"Evaluation of risk factors for patients suffering from diabetic foot ulcer","volume":"5","author":"Das","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejphar.2023.176083_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0041-1731460","article-title":"Updates in diabetic wound healing, inflammation, and scarring","volume":"35","author":"Dasari","year":"2021","journal-title":"Semin. Plast. Surg."},{"key":"10.1016\/j.ejphar.2023.176083_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8852759","article-title":"The role of oxidative stress and antioxidants in diabetic wound healing","volume":"2021","author":"Deng","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176083_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2016.01.006","article-title":"Alagebrium attenuates methylglyoxal induced oxidative stress and AGE formation in H9C2 cardiac myocytes","volume":"146","author":"Dhar","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.176083_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2016.01.006","article-title":"Alagebrium attenuates methylglyoxal induced oxidative stress and AGE formation in H9C2 cardiac myocytes","volume":"146","author":"Dhar","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.176083_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4239\/wjd.v13.i1.27","article-title":"Management of diabetic foot ulcers and the challenging points: an endocrine view","volume":"13","author":"Do\u011fruel","year":"2022","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2023.176083_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","article-title":"Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications","volume":"30","author":"Domingueti","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ejphar.2023.176083_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcot.2021.01.017","article-title":"The current burden of diabetic foot disease","volume":"17","author":"Edmonds","year":"2021","journal-title":"J. Clin. Orthopaed. Trauma"},{"key":"10.1016\/j.ejphar.2023.176083_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijbiomac.2016.10.113","article-title":"Cell physiology regulation by hypoxia inducible factor-1: targeting oxygen-related nanomachineries of hypoxic cells","volume":"99","author":"Eskandani","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2023.176083_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176083_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ijir.2011.54","article-title":"Therapeutic effect of combination of alagebrium (ALT-711) and sildenafil on erectile function in diabetic rats","volume":"24","author":"Gurbuz","year":"2012","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.ejphar.2023.176083_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/2347-9264.165438","article-title":"Role of angiogenesis and angiogenic factors in acute and chronic wound healing","volume":"2","author":"Honnegowda","year":"2015","journal-title":"Plast. Aesthetic Res."},{"key":"10.1016\/j.ejphar.2023.176083_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2019.11.004","article-title":"High glucose environment induces M1 macrophage polarization that impairs keratinocyte migration via TNF-\u03b1: an important mechanism to delay the diabetic wound healing","volume":"96","author":"Huang","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2023.176083_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1258\/002367704323133664","article-title":"A replacement for methoxyflurane (Metofane) in open-circuit anaesthesia","volume":"38","author":"Itah","year":"2004","journal-title":"Lab. Anim"},{"key":"10.1016\/j.ejphar.2023.176083_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0192623318776907","article-title":"Immunohistochemistry in investigative and toxicologic pathology","volume":"46","author":"Janardhan","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2023.176083_bib23","first-page":"395","article-title":"End-stage complications of diabetic neuropathy","volume":"7","author":"Jude","year":"1999","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.ejphar.2023.176083_bib24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.176083_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000122834","article-title":"An in vivo investigation on the wound-healing effect of two medicinal herbs using an animal model with foot ulcer","volume":"41","author":"Lau","year":"2008","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.ejphar.2023.176083_bib26","doi-asserted-by":"crossref","first-page":"H106","DOI":"10.1152\/ajpheart.00110.2012","article-title":"Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice","volume":"303","author":"Lee","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2023.176083_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.717740","article-title":"Lipid oxidation products on inflammation-mediated hypertension and atherosclerosis: a mini review","volume":"8","author":"Leong","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ejphar.2023.176083_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40257-017-0275-z","article-title":"Cutaneous manifestations of diabetes mellitus: a review","volume":"18","author":"Lima","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejphar.2023.176083_bib29","first-page":"430","article-title":"The role of keratinocyte function on the defected diabetic wound healing","volume":"11","author":"Mansoub","year":"2021","journal-title":"Int. J. Burns Trauma"},{"key":"10.1016\/j.ejphar.2023.176083_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-8981(02)00097-9","article-title":"Glucose-mediated cross-linking of collagen in rat tendon and skin","volume":"321","author":"Mentink","year":"2002","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.ejphar.2023.176083_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231962","article-title":"Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing","volume":"15","author":"Okonkwo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176083_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.176083_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867053363207","article-title":"Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies","volume":"12","author":"Pacher","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176083_bib34","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/ndt\/gfr152","article-title":"Renoprotective antioxidant effect of alagebrium in experimental diabetes","volume":"26","author":"Park","year":"2011","journal-title":"Nephrol. Dial. Transplant. : Off. Publ. Eur. Dial. Transplant Assoc. Eur. Renal Assoc."},{"key":"10.1016\/j.ejphar.2023.176083_bib35","series-title":"BioSpace","article-title":"Alteon (ALT) temporarily suspends enrollment of new patients in clinical trials of alagebrium pending additional preclinical data","author":"Pietropaolo","year":"2005"},{"key":"10.1016\/j.ejphar.2023.176083_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/09546634.2012.713459","article-title":"The beneficial effects of Momordica charantia (bitter gourd) on wound healing of rabbit skin","volume":"25","author":"Pi\u015fkin","year":"2014","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejphar.2023.176083_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncpendmet0347","article-title":"The neuropathic diabetic foot","volume":"3","author":"Rathur","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2023.176083_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000658-198107000-00008","article-title":"Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A","volume":"194","author":"Seifter","year":"1981","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejphar.2023.176083_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ibneur.2022.02.001","article-title":"Peripheral neuropathy in the pre-diabetic state of the type 2 diabetes mouse model (TSOD mice) involves TRPV1 expression in dorsal root ganglions","volume":"12","author":"Shida","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.ejphar.2023.176083_bib40","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/biom12111659","article-title":"Macrophages in skin wounds: functions and therapeutic potential","volume":"12","author":"Sim","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2023.176083_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2023.176083_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharmacol.: Off. J. Kor. Physiol. Soc. Kor. Soc. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176083_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrm3675","article-title":"Regenerating the skin: a task for the heterogeneous stem cell pool and surrounding niche","volume":"14","author":"Solanas","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.176083_bib44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1517\/13543784.11.9.1205","article-title":"Advanced glycation end products and diabetic complications","volume":"11","author":"Stitt","year":"2002","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2023.176083_bib45","doi-asserted-by":"crossref","DOI":"10.3791\/59027","article-title":"Low-cost protocol of footprint analysis and hanging box test for mice applied the chronic restraint stress","author":"Sugimoto","year":"2019","journal-title":"JoVE"},{"key":"10.1016\/j.ejphar.2023.176083_bib46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-\u03ba\u03b2: a potential target in the management of vascular complications of diabetes","volume":"8","author":"Suryavanshi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176083_bib47","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2337\/diabetes.53.11.2921","article-title":"Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway","volume":"53","author":"Thallas-Bonke","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.176083_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2023.176083_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5152\/eurasianjmed.2019.18434","article-title":"Alagebrium and complications of diabetes mellitus","volume":"51","author":"Toprak","year":"2019","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.ejphar.2023.176083_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.abb.2003.08.016","article-title":"Therapeutic potential of breakers of advanced glycation end product\u2013protein crosslinks","volume":"419","author":"Vasan","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2023.176083_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkaa028","article-title":"Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization","volume":"8","author":"Xu","year":"2020","journal-title":"Burns Trauma"},{"key":"10.1016\/j.ejphar.2023.176083_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9570616","article-title":"Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176083_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1538\/expanim.17-0016","volume":"66","author":"Yu","year":"2017","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejphar.2023.176083_bib54","article-title":"Targeting AGEs signaling ameliorates central nervous system diabetic complications in rats","volume":"2015","author":"Zakaria","year":"2015","journal-title":"Adv. Pharmacol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:19:48Z","timestamp":1757978388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923005952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":54,"alternative-id":["S0014299923005952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176083","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs\/NF\u03baB\/NOX1 signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176083"}}